Institutional investors purchased a net $228.3 thousand shares of RGLS during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 60.15% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FOX RUN MANAGEMENT LLC Bought 33.1 Thousand shares of Regulus Therapeutics Inc
CUTLER GROUP LP Bought 4.5 Thousand shares of Regulus Therapeutics Inc